IBio Analyst Ratings
Brookline Capital Initiates Coverage On IBio With Buy Rating, Announces Price Target of $3.6
Brookline Capital Initiates IBio Inc(IBIO.US) With Buy Rating, Announces Target Price $3.6
IBio Analyst Ratings
Chardan Capital Maintains Buy on IBio, Maintains $5 Price Target
IBio Analyst Ratings
Ibio Inc: Chardan Capital Markets launches report with a buy rating; target price is $5
Chardan Research Starts IBio With Buy Rating, $5 Price Target
IBio Analyst Ratings
No Data
No Data